Muhammad Akram Khatri

Assessment of Patient’s Response about Adverse Drug Reactions Receiving AC (Adriamycin, Cyclophosphamide) Therapy: A Survey Research

Jameela Jamali, Abdullah Dayo, Naheed Memon, Ubed-ur-Rehman Mughal, Muhammad Akram Khatri, Shaib Muhammad, Yasmeen Qureshi & Tooba Khan · Journal of Pharmaceutical Research International · 2021

Background: Adverse drug reactions (ADRs) are most common among cancer patients receiving treatment. AC therapy which is a combination protocol of Adriamycin (doxorubicin) and Cyclophosphamide are the common therapies used for breast cancer treatment due to their effectiveness an...

Open access Research Article 10.9734/jpri/2021/v33i26A31467

Evaluation of Different Brands of Cefixime Available in Pakistan by Newly Developed Spectrophotometric Method

Madan Lal Maheshwari, Ubed-ur-Rahman Mughal, Geeta Kumari, Bilawal Shaikh, Maryam Qazi, Hosh Muhammad Lashari, Muhammad Akram Khatri, Narendar Kumar, Dharam Dev & Saeed Ahmed Lakho · Journal of Pharmaceutical Research International · 2021

A fast, simple and valued method is developed to observe the quality and quantity of different pharmaceutical brands of cefixime. A spectrophotometric method has been developed for analysis of cefixime (CFX) by reacting with 4-dimethylamino benzaldehyde (DAB) as derivatizing agen...

Open access Research Article 10.9734/jpri/2021/v33i29A31576